Trial intelligence / Profile preview

Nocturnal Dexamethasone in Congenital Adrenal Hyperplasia

NCT00621985Phase 2Completed

Sponsor
Boston Children's Hospital
Start
Apr 2008
Primary completion
Jun 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of dexamethasone in congenital adrenal hyperplasia (CAH), sponsored by Boston Children's Hospital. Started Apr 2008; status: completed.

02

Drugs

dexamethasone
03

Conditions

congenital adrenal hyperplasia (CAH)

Beyond the preview

Go deeper on NCT00621985.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00621985.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call